Nyberg G, Karlén B, Hedlund I, Grundin R, von Bahr C
Acta Pharmacol Toxicol (Copenh). 1977 Feb;40(2):337-46. doi: 10.1111/j.1600-0773.1977.tb02086.x.
The use of lidocaine as an oral antiarrhythmic drug is limited by its rapid disposition in the liver. In accordance with this we found that the drug was completely extracted during one passage through the perfused rat liver. The drug binds to rat liver microsomes with a type I spectral change of unusually high affinity. It is rapidly de-ethylated by the microsomes with an apparent Vmax of about 15 nmol per mg protein x min. The apparent Km for this reaction is about 250 muM. The reaction occures at about the same rate in isolated rat liver cells. We believe that the high affinity of lidocaine for the cytochrome P-450 system, as indicated by its type I spectral change, as well as the rapid oxidation of the drug are the two main determinants for the marked liver extraction and first pass effect of the drug.
利多卡因作为口服抗心律失常药物的应用受到其在肝脏中快速代谢的限制。据此我们发现,该药物在流经灌注大鼠肝脏的过程中被完全提取。该药物与大鼠肝脏微粒体结合时呈现出具有异常高亲和力的I型光谱变化。它被微粒体迅速脱乙基,表观Vmax约为每毫克蛋白质每分钟15纳摩尔。该反应的表观Km约为250微摩尔。在分离的大鼠肝细胞中,该反应以大致相同的速率发生。我们认为,利多卡因对细胞色素P - 450系统的高亲和力(如I型光谱变化所示)以及药物的快速氧化是该药物显著肝脏提取和首过效应的两个主要决定因素。